Expertise in
9
conditions

Dr. Veronica Franco

Advanced Heart Failure and Transplant Cardiology | Cardiology
Osu Internal Medicine LLC
920 N Hamilton Rd, 
Gahanna, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
9
conditions
Osu Internal Medicine LLC
920 N Hamilton Rd, 
Gahanna, OH 

Overview

Veronica Franco is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Gahanna, Ohio.

Dr. Franco is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Cardiac Ablation.

She is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 14 clinical trials. Dr. Franco is currently accepting new patients.

Specialties

Advanced Heart Failure and Transplant Cardiology
Cardiology

Licenses

Internal Medicine in OH

Hospital Affiliations

Ohio State University State Health System
Fairfield Medical Center

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

OSU INTERNAL MEDICINE LLC
920 N Hamilton Rd, Gahanna, OH 43230

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

RELIEVE-PAH TRIAL: REducing Right ventricuLar faIlure With thE V-waVe Shunt in Pulmonary Arterial Hypertension
RELIEVE-PAH TRIAL: REducing Right ventricuLar faIlure With thE V-waVe Shunt in Pulmonary Arterial Hypertension
Enrollment Status: Recruiting
Publish Date: March 31, 2026
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: April 14, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 2b, Open-label, Single Dose Study to Evaluate the Safety and Efficacy of RT234 on Exercise Parameters Assessed by Cardiopulmonary Exercise Testing (CPET) in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2b, Open-label, Single Dose Study to Evaluate the Safety and Efficacy of RT234 on Exercise Parameters Assessed by Cardiopulmonary Exercise Testing (CPET) in Subjects With Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Completed
Publish Date: September 18, 2025
Intervention Type: Combination product
Study Drug: RT234
Study Phase: Phase 2
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 07, 2023
Intervention Type: Drug
Study Drug: Intravenous/Subcutaneous Treprostinil
Study Phase: Phase 4
Dietary Supplementation in Heart Failure
Dietary Supplementation in Heart Failure
Enrollment Status: Completed
Publish Date: October 22, 2021
Intervention Type: Dietary supplement
Study Phase: Not Applicable
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

24 Total Publications

Corrigendum to ''Sotatercept use in a patient with pulmonary arterial hypertension undergoing lung transplantation'' [JHLT Open (2025) 100213].
Corrigendum to ''Sotatercept use in a patient with pulmonary arterial hypertension undergoing lung transplantation'' [JHLT Open (2025) 100213].
Journal: JHLT open
Published: December 01, 2025
Similar Doctors
Expertise in
9
conditions
Dr. William T. Abraham
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
9
conditions
Dr. William T. Abraham
Advanced Heart Failure and Transplant Cardiology | Cardiology

Osu Internal Medicine LLC

3900 Stoneridge Ln, 
Dublin, OH 
 (12.9 miles away)
614-366-5001
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Abraham is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Dublin, Ohio. Dr. Abraham is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Heart Failure, Mitral Valve Regurgitation, Pulmonary Edema, Cardiomyopathy, and Heart Transplant. Dr. Abraham is currently accepting new patients.

Expertise in
21
conditions
Dr. Garrie J. Haas
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
21
conditions
Dr. Garrie J. Haas
Advanced Heart Failure and Transplant Cardiology | Cardiology

Osu Internal Medicine LLC

3900 Stoneridge Ln, 
Dublin, OH 
 (12.9 miles away)
614-366-5001
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Garrie Haas is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Dublin, Ohio. Dr. Haas is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Dilated Cardiomyopathy (DCM), Cardiomyopathy, Long QT Syndrome 2, Heart Transplant, and Cardiac Ablation. Dr. Haas is currently accepting new patients.

Expertise in
28
conditions
Dr. Ragavendra R. Baliga
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
28
conditions
Dr. Ragavendra R. Baliga
Advanced Heart Failure and Transplant Cardiology | Cardiology

Osu Internal Medicine LLC

452 W 10th Ave, 
Columbus, OH 
 (8.8 miles away)
614-293-3737
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ragavendra Baliga is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Columbus, Ohio. Dr. Baliga is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Familial Ventricular Tachycardia, Timothy Syndrome, Long QT Syndrome 3, Cardiac Ablation, and Pacemaker Implantation. Dr. Baliga is currently accepting new patients.

Frequently Asked Questions about Dr. Veronica Franco

How do I make an appointment with Dr. Veronica Franco?

You can book an appointment with Dr. Veronica Franco by calling their office at 614-293-2663. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Veronica Franco a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Veronica Franco is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Veronica Franco specialize in?

While Dr. Veronica Franco is a Advanced Heart Failure and Transplant Cardiology, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Heart Failure with Preserved Ejection Fraction (HFpEF). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Advanced Heart Failure and Transplant Cardiology.

Does Dr. Veronica Franco participate in research or clinical trials?

Yes. Dr. Veronica Franco has published 24 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Veronica Franco's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Veronica Franco accept my insurance?

Dr. Veronica Franco accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-293-2663 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Franco's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile